20 May 2026
EU Pharmaceutical Package | Part I – Regulatory Data & Market Protection, Orphan Market Exclusivity, Bolar Exemption and Antimicrobial Vouchers
15 min read
This is our first news alert on the pharmaceutical package, as released in March 2026, addressing four commercially critical areas: (i) regulatory data and market protection; (ii) market exclusivity for orphan medicinal products; (iii) the Bolar exemption; and (iv) the new transferable exclusivity vouchers for priority antimicrobials.
See more via the below note
Attachments:
Key contacts
News & insights
10 min
read
read
Briefings
Dual-Use Items: AG Backs Broad Test in Case C-538/25
13 October 2026
1 min
read
read
Briefings
EU General Court Ruling on Customs Classification of Split Consignments in EU Assembly Operations
9 October 2026
2 min
read
read
Briefings
Poland – Polish Competition Authority Fines Medicine Wholesalers for Illegally Exchanging Confidential Information
23 September 2026
2 min
read
read
Briefings
Belgian Competition Authority Imposes fine of EUR 29.8 Million on Pharmaceutical Wholesaler Pharma Belgium-Belmedis
18 February 2022
2 min
read
read
Briefings
Belgium Publishes Third Annual Report Regarding Screening of Foreign Direct Investment
11 September 2026
10 min
read
read
Briefings
Public procurement rules being set aside in European defence deals
21 September 2026
4 min
read
read
Briefings
Belgian Competition Authority Closes Live Nation / Pukkelpop Investigation on Commitments
21 September 2026
5 min
read
read
Briefings
Urban Wastewater Treatment Directive Remains Focus of Litigation and Parliamentary Activity
15 September 2026
